DJIA 17,991.97 279.31 1.58%
NASDAQ 4,938.55 47.33 0.97%
S&P 500 2,085.13 24.11 1.17%
market minute promo

Pfizer (NYSE: PFE)

company name or ticker
Company Photos
(Click to zoom)

Why AbbVie Inc.'s $21 Billion Deal Had To Happen

AbbVie Inc has agreed to pay $21 billion to acquire Pharmacyclics, Inc.

3 Little-Known Stocks I'm Glad I Bought

Ophthotech Corp, Portola Pharmaceuticals Inc., and Insys Therapeutics Inc., have been top performers this past year.

Did Pfizer Inc. Just Gut Its Chances of Finding New Blockbusters?

Pfizer Inc. continues to adjust its R&D spending to offset slipping sales.

2 Tiny Biotechs That Could Have Blockbuster Opportunity

Got risk tolerance? Check out these two small cap biotechs with huge potential.

3 Big Pharma Stocks to Buy in March

Our experts weigh in.

Regeneron Jumps Ahead In $10 Billion Race For Next Generation Cardio Drugs

3 Prevailing Myths About Dividend Stocks

If you invest in dividend stocks, here are three popular myths you need to learn the truth about

Pfizer's Strong FCF Means Big Dividend Growth

Pfizer's Prevenar Cleared in the EU for New Indication - Analyst Blog

Stock Market News for March 05, 2015 - Market News